The value of fluorine-18 deoxyglucose positron emission tomography scans in patients with ventricular assist device specific infections

European Journal of Cardio-thoracic Surgery

Volumn 51, Issue 6, 2017, Pages 1072-1077

  Bernhardt, Alexander M ^a   Pamirsad, Mustafa A ^a   Brand, Chantal ^a   Reichart, Daniel ^a   Tienken, Milena ^b   Barten, Markus J ^a   Schaefer, Andreas ^a   Grahn, Hanno ^a   Rybczynski, Meike ^a   Deuse, Tobias ^a,c   Reichenspurner, Hermann ^a   Wagner, Florian M ^a  

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY OF SAN FRANCISCO   (United States)

Author keywords

Computed tomography; Diagnostic; Infection; Ventricular assist device

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEVICE INFECTION; FEMALE; FOLLOW UP; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VENTRICULAR ASSIST DEVICE; VENTRICULAR ASSIST DEVICE ASSOCIATED INFECTION; ADVERSE DEVICE EFFECT; AGED; DIAGNOSTIC IMAGING; HEART ASSIST DEVICE; INFECTION; MIDDLE AGED;

ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES;

EID: 85021808314     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezx016     Document Type: Article

References (15)

1. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED et al. Seventh INTERMACS annual report: 15, 000 patients and counting. J Heart Lung Transplant 2015;34:1495-504
2. Healy AH, Baird BC, Drakos SG, Stehlik J, Selzman CH. Impact of ventricular assist device complications on posttransplant survival: an analysis of the United network of organ sharing database. Ann Thorac Surg 2013;95:870-5
3. Hannan MM, Husain S, Mattner F, Danziger-Isakov L, Drew RJ, Corey GR et al. Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. J Heart Lung Transplant 2011;30:375-84
4. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA et al. Second INTERMACS annual report: more than 1, 000 primary left ventricular assist device implants. J Heart Lung Transplant 2010;29:1-10
5. Monkowski DH, Axelrod P, Fekete T, Hollander T, Furukawa S, Samuel R. Infections associated with ventricular assist devices: epidemiology and effect on prognosis after transplantation. Transpl Infect Dis 2007;9:114-20
6. Goldstein DJ, Naftel D, Holman W, Bellumkonda L, Pamboukian SV, Pagani FD et al. Continuous-flow devices and percutaneous site infections: clinical outcomes. J Heart Lung Transplant 2012;31:1151-7
7. Topkara VK, Kondareddy S, Malik F, Wang I-W, Mann DL, Ewald GA et al. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era. Ann Thorac Surg 2010;90:1270-7
8. Koval CE, Thuita L, Moazami N, Blackstone E. Evolution and impact of drive-line infection in a large cohort of continuous-flow ventricular assist device recipients. J Heart Lung Transplant 2014;33:1164-72
9. Gordon RJ, Weinberg AD, Pagani FD, Slaughter MS, Pappas PS, Naka Y et al. Ventricular Assist Device Infection Study Group. Prospective, multicenter study of ventricular assist device infections. Circulation 2013;127:691-702
10. Argenziano M, Catanese KA, Moazami N, Gardocki MT, Weinberg AD, Clavenna MW et al. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant 1997;16:822-31
11. Herrmann M, Weyand M, Greshake B, von Eiff C, Proctor RA, Scheld HH et al. Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation. Circulation 1997;95:814-7
12. Dell'Aquila AM, Mastrobuoni S, Alles S, Wenning C, Henryk W, Schneider SRB et al. Contributory role of fluorine 18-fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis and clinical management of infections in patients supported with a continuousflow left ventricular assist device. Ann Thorac Surg 2016;101:87-94; discussion 94
13. Amin R, Charron M, Grinblat L, Shammas A, Grasemann H, Graniel K et al. Cystic fibrosis: detecting changes in airway inflammation with FDG PET/CT. Radiology 2012;264:868-75
14. Levy DT, Minamoto GY, Da Silva R, Puius YA, Peck N, Goldstein D et al. Role of gallium SPECT-CT in the diagnosis of left ventricular assist device infections. ASAIO J 2015;61:e5-10
15. Litzler P-Y, Manrique A, Etienne M, Salles A, Edet-Sanson A, Vera P et al. Leukocyte SPECT/CT for detecting infection of left-ventricular-assist devices: preliminary results. J Nucl Med 2010;51:1044-48